CIK 0000749647 · Non-accelerated filer<br>Smaller reporting company
Imunon, Inc.
Sign in to watch- Ticker
- IMNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521256615
- Phone
- (609) 896-9100
- Business address
- 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ, 08648
- Former names
- CELSION CORP, Celsion CORP, CHEUNG LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,942
- in 2 filings
Net −$7,942. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-04 | Braun Donald P Director | Grant or award | +2,040 | $9.20 | $19K | 3,747 |
| 2025-08-04 | Braun Donald P Director | Grant or award · Stock Option (Right to Buy) | +250 | 250 | ||
| 2025-08-04 | Fritz Frederick J. Director | Grant or award | +3,161 | $9.20 | $29K | 3,946 |
| 2025-08-04 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +250 | 250 | ||
| 2025-08-04 | Anwer Khursheed Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +1,667 | 1,667 | ||
| 2025-08-04 | Bragg Kimberly CFO | Grant or award · Stock Option (Right to Buy) | +667 | 667 | ||
| 2025-08-04 | Eylward Susan General Counsel and Corp Sec | Grant or award · Stock Option (Right to Buy) | +417 | 417 | ||
| 2025-08-04 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +1,667 | 1,667 | ||
| 2025-08-04 | Lindborg Stacy President and CEO | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-03-14 | Fritz Frederick J. Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2025-03-14 | Braun Donald P Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2025-03-14 | Eylward Susan General Counsel and Corp Sec | Grant or award · Stock Option (Right to Buy) | +6,250 | 6,250 | ||
| 2025-03-14 | Dentzer James E Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2025-03-14 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-03-14 | Pellizzari Christine A Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2025-03-14 | Lindborg Stacy President and CEO | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2025-02-18 | Faller Douglas Vincent Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-12-18 | Tardugno Michael H Executive Chairman of Board | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-10-07 | Eylward Susan General Counsel and Corp Sec | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-09-06 | Lindborg Stacy President and CEO | Grant or award · Restricted Stock Units | +25,000 | 25,000 |
Page 5 of 6 · 119 trades